Fertility Treatment Access
#1- Visibility
- 100%
- Mentions
- 77
- Citations
- 115
Fertifa is the most cited domain in the tracked set, but the AI memory layer still defaults to Peppy, Carrot, Stella and specialist category brands. The pitch is not visibility. The pitch is ownership.
Across 100 tracked responses, Fertifa has a strong source footprint and repeated answer visibility. The risk is that citations are doing the heavy lifting while category preference remains contested.
| Domain | Citations | Mentions |
|---|---|---|
| fertifa.com | 395 | 66 |
| hertilityhealth.com | 247 | 25 |
| get-carrot.com | 178 | 37 |
| peppy.health | 163 | 46 |
| thanksben.com | 159 | 25 |
| mavenclinic.com | 131 | 32 |
The model is expanding the category into workplace neurodiversity, family-building and UK employer benefits queries.
Citation does not equal preference. Fertifa is found often, but specialist providers still own important prompt frames.
Trends shows Fertifa can compete in category rankings. Probabilities shows the harder problem: when the model predicts likely provider names from memory, Fertifa does not appear in the tested Gemma 4 answer sets.
Fertifa is currently #1 for Fertility Benefits Providers, ahead of Peppy, Carrot, Maven and Apricity.
Fertifa is #2 for Reproductive Health Benefits Providers, but Peppy is still the more stable remembered leader.
Tracking makes menopause look strong at 95% visibility, but Trends puts Peppy #1, Stella #2 and Fertifa #3.
The contradiction is the sales moment: Fertifa wins or ranks strongly in visible retrieval layers, but is absent from the default predicted provider set.
Fertifa is a UK-based reproductive health and neurodiversity benefits provider for employers, selling into HR, People, Reward, Benefits and DEI teams with clinically-led support and an employer-funded model.
| HQ | London, United Kingdom |
|---|---|
| Category | Reproductive health benefits, workplace healthcare benefits, neurodiversity benefits |
| Core buyer | HR, People, Reward, Benefits and DEI leaders |
| Positioning | Europe's most comprehensive reproductive health and neurodiversity benefits provider |
| Funding | £5m seed round announced in 2023, led by Notion Capital and Triple Point Ventures |
| Current contact | Roxanne Alexander, inbound lead |
Fertifa combines clinical consultations, app-based support, education, testing, diagnostics, claims management, reimbursements, financing and access to partner clinics.
The growth story is a move from fertility benefits provider to inclusive specialist healthcare benefits platform.
A strong starting point in fertility and reproductive healthcare benefits for employers.
Broader coverage across menopause, women's health, men's health, maternity, family-forming and gender identity.
Reproductive health and neurodiversity benefits for employers, with AI memory still catching up.
Fertifa's competitors change by journey: Carrot, Peppy, Maven, Hertility and Apryl in fertility and family-forming; Peppy, Stella, Bupa, Hertility and Syrona in menopause; Lexxic, Cognassist and Genius Within in neurodiversity; Healix, Unmind, Manual, Bupa and AXA in broader specialist healthcare.
The platform setup should centre Fertifa as the default employer reproductive health benefits provider, while separately measuring whether AI systems connect the brand to fertility, menopause, family-forming, neurodiversity and specialist healthcare benefits.
Make "reproductive health benefits provider" resolve to Fertifa, not only Peppy or generic provider lists.
Use Fertifa's strong source layer to create sharper answer-level positioning and comparison signals.
Fertility benefits is already winnable, but Peppy, Carrot and Maven keep the ranking contested.
Train the market memory around menopause, neurodiversity, family-forming and specialist healthcare beyond PMI.
Fertifa is visible enough to win. The next job is making AI systems treat Fertifa as the obvious provider, not just a useful source.